Contact us
search
ENG
Deutsch
Français
Contact us
  • There are no suggestions because the search field is empty.
Service Area
Health Canada Medical Regulations

Our regulatory experts support manufacturers in achieving and maintaining compliance with Health Canada Medical Device Regulations requirements, guiding you through the registration process, documentation, and local representation to ensure fast and successful market access in Canada.

Regulatory compliance for Canada

Regulatory compliance for Canada

If you are new to the Health Canada Medical Device Regulations, it can be difficult to navigate through the various regulations, guidance documents, and requirements. Health Canada is the department of the Canadian Government responsible for the national health policy. Regarding medical devices, Health Canada is taking care of the issuance and maintenance of medical device licenses. Medical devices are regulated in Canada according to SOR/98-282.

Canada is part of the Medical Device Single Audit Program (MDSAP) and co-founder of the International Medical Device Regulators Forum (IMDRF).

The Canadian risk-based classification of medical devices is subdivided into four classes: I (low risk), II (medium risk), III (high risk), and IV (maximum risk). Manufacturers must follow the 16 classification rules presented in Schedule 1 (Part 1) of SOR/98-282 to ensure the correct classification of the medical device. Manufacturers of Class I medical devices are required to obtain a Medical Device Establishment License (MDEL). At the same time, manufacturers of higher-risk class devices such as Class II/III/IV must obtain a Medical Device License (MDL) to sell their medical devices legally in Canada.
 
There are substantial differences in the classification and rules for IVDs compared to medical devices. These can be found in Schedule 1 (Part 2) of SOR/98-282 and exist of 9 rules. Please contact our experts for more information.

Get Support Now
Health Canada Medical Regulations
Services

Qserve services for Canada

Global Regulatory Strategy

Canada is an attractive market for medical device manufacturers for several reasons. The Canadian medical device industry is highly diversified, with a market size estimated to be US$6.8 billion in 2022 and expected to grow by 5.4% annually until 2028. Canada's aging population provides an opportunity to focus on medical devices to aid older population groups. To understand the most feasible and effective approach to entering the Canadian market, Qserve can help determine your global regulatory strategy.

Medical Device Registration and IVDs

Our regulatory consulting specialists support market access in the Canadian medical device market. Based on your current compliance, we can conduct a gap analysis to determine the overlap and missing elements in completing the technical documentation efficiently. Qserve experts ensure full compliance and successful market entry for medical devices and IVDs in Canada.

Risk classification assessment

Our team of regulatory experts helps determine the correct risk class for your medical device in alignment with Health Canada’s Medical Devices Regulations (SOR/98-282). A proper classification ensures the right pathway for licensing, documentation, and quality system requirements—minimizing delays and maximizing your chance of a successful submission. We assess your product's intended use, technology, and claims to identify the correct classification and define next steps for compliance.

Build Canada-compliant technical documentation

We support manufacturers in developing or adapting their technical files in accordance with the Health Canada requirements. Whether you are entering the market for the first time or updating existing documentation, our specialists ensure all required elements are thoroughly addressed and compliant with the latest Canadian expectations.

Build MDSAP-compliant quality management system (QMS)

To sell Class II, III, or IV devices in Canada, manufacturers must have a certified QMS under the Medical Device Single Audit Program (MDSAP). We guide you in designing, implementing, or upgrading your QMS to meet MDSAP requirements, which align with ISO 13485:2016 and additional country-specific requirements, including those of Health Canada.

Translations of labels and IFUs based on requirements

Canada’s bilingual labeling requirements mean that medical device labels and Instructions for Use (IFUs) must be available in both English and French. We provide high-quality, regulatory-grade translations that meet Health Canada’s standards, including terminology accuracy, layout consistency, and timely delivery. 

Conformity Assessment Route Support

We help identify and follow the appropriate conformity assessment route for your product, ensuring regulatory compliance and efficient approval.

Risk Classification Assessment

We support you in determining the correct risk class for your medical device under Health Canafa, which is essential for defining your regulatory pathway.

Gap Analysis

Our team reviews your documentation and systems to identify gaps against Health Canada regulatory requirements, helping you prepare a complete submission.

Risk Management Support

We help you develop or align your risk management files in accordance with ISO 14971 and local Health Canada expectations.

Clinical Evaluation & Studies

Qserve assists in collecting and presenting relevant clinical data, including literature reviews or local study coordination, when required for registration.

Post-Market Surveillance (PMS)

We support your PMS planning and activities, including complaint handling and vigilance, in line with Health Canada post-market expectations.

Registration routes in Canada

Regulatory Process

Should the manufacturer of Class I medical devices or in vitro diagnostic devices aim to market their products directly in Canada without utilizing a distributor, they are obligated to obtain a Medical Device Establishment License (MDEL). If the manufacturer opts for distribution through one or more distributors within Canada, they must also undergo the application process for an MDEL. Put differently, distributors and importers based in Canada must apply for an MDEL, irrespective of the risk classification of the medical device or in vitro diagnostic device.

For manufacturers dealing with Class II-IV devices intending to sell their products, applying for an MDL is the prerequisite. The key distinction between an MDEL and an MDL lies in the fact that the MDL constitutes product approval, while the MDEL serves as a permit for the company, distributor, or importer itself.

In obtaining an MDL, manufacturers are required to demonstrate certification under the ISO 13485 quality management system through the Medical Device Single Audit Program (MDSAP). This certification must align with the specifications outlined in the Health Canada Medical Regulations.

Both license application procedures require submitting documents in electronic format to Health Canada, following the submission requirements set by Health Canada.

Guidence documents
 

- Health Canada

- Legislation guidelines.

Market Access
More information
Get in touch for more information about Canada Market Access
language
Language requirements

The submission documentation, label and IFU must be in English.Unlike other countries, Health Canada does not require foreign manufacturers to appoint a local representative as a prerequisite to place their devices on the Canadian market.

timeline
Regulatory timelines and fees

In general, Health Canada needs 4-5 months for an MDEL and about 2-3 weeks for a Class II MDL, 2-3 months for a Class III MDL, and 4-5 months for a Class IV MDL. This can vary significantly depending on the complexity of the device, the quality of the documentation submitted, the device's risk class, and the efficiency of the submission process.

Market Access
More information
power
Language requirements

How to communicate with the authorities? The submission documentation, label and IFU must be in English. Unlike other countries, Health Canada does not require foreign manufacturers to appoint a local representative as a prerequisite to place their devices on the Canadian market.

power
Regulatory timelines and fees

Entering the Canadian medical market In general, Health Canada needs 4-5 months for an MDEL and about 2-3 weeks for a Class II MDL, 2-3 months for a Class III MDL, and 4-5 months for a Class IV MDL. This can vary significantly depending on the complexity of the device, the quality of the documentation submitted, the device's risk class, and the efficiency of the submission process.

power
Guidance documents

https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-devices.html https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-devices/legislation-guidelines.html

server render fail/waiting for island-7f870ei1R0 (separate island render, inside)